Insider Transactions in Q2 2022 at Spring Works Therapeutics, Inc. (SWTX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2022
|
L. Mary Smith Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,092
+3.04%
|
-
|
|
Jun 30
2022
|
Michael F. Burgess Head of Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
12,185
+18.78%
|
-
|
|
Jun 01
2022
|
Michael F. Burgess Head of Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
2,672
-6.19%
|
$50,768
$19.61 P/Share
|
|
May 19
2022
|
Freda C Lewis Hall Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,818
+44.85%
|
-
|
|
May 19
2022
|
Julie Hambleton Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,818
+44.85%
|
-
|
|
May 19
2022
|
Alan Fuhrman Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,818
+44.85%
|
-
|
|
May 19
2022
|
Daniel Lynch Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,818
+1.6%
|
-
|
|
May 19
2022
|
Stephen P Squinto Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,818
+3.53%
|
-
|
|
May 19
2022
|
Jeffrey Lawrence Schwartz Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,818
+44.85%
|
-
|
|
Apr 01
2022
|
Bhavesh Ashar Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,464
-5.73%
|
$81,984
$56.9 P/Share
|